XML 79 R60.htm IDEA: XBRL DOCUMENT v3.3.1.900
DISPOSITIONS AND HELD FOR SALE (Details) - USD ($)
$ in Millions
1 Months Ended 3 Months Ended 12 Months Ended
Jul. 01, 2015
Jul. 18, 2013
Sep. 30, 2013
Sep. 30, 2015
Dec. 31, 2015
Dec. 31, 2014
Dec. 31, 2013
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]              
Investment in equity method investee         $ 33 $ 0 $ 0
Equity method investments carrying value         473 46  
Pre-tax gain (loss) recognized         334 0 0
Deferred tax liability         112 23 19
Gain on sale of royalty rights   $ (474)     0 $ 0 $ 474
Non-core Assets Held for Sale [Member]              
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]              
Goodwill reclassified to current assets held-for-sale         113    
Enterix [Member]              
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]              
Pre-tax gain (loss) recognized     $ (40)        
Royalty Agreement Terms [Member] | Ibrutinib [Member]              
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]              
Proceeds from sale of intangible assets   $ 485          
Q² Solutions [Member]              
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]              
Investment in equity method investee $ 33            
Equity method investment, ownership percentage 40.00%            
Equity method investments carrying value         416    
Deferred tax liability         $ 145    
Excess of equity in underlying net assets $ 219            
Q² Solutions [Member] | Equity Method Investment, Basis Difference [Member]              
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]              
Amount allocated to finite-lived intangible assets $ 75            
Finite-lived intangible assets, remaining amortization period 8 years            
Clinical Trials [Member]              
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]              
Pre-tax gain (loss) recognized       $ 334      
Deferred tax liability       $ 145